DUO: A phase 3 trial of the PI3K-δ,γ inhibitor IPI-145 versusofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 32; no. 15_suppl; p. TPS7122
Main Authors Flinn, Ian, Jäger, Ulrich, Offner, Fritz, Cymbalista, Florence, Hallek, Michael, Caligaris-Cappio, Federico, Delgado, Julio, Hillmen, Peter, Davids, Matthew Steven, Wright, David Donald, Essell, James H., Baker, Bartrum W, Cosolo, Walter, Kelly, Patrick Francis, Harris, Patricia, Han, Lixin, Patterson, Fiona, Stilgenbauer, Stephan
Format Journal Article
LanguageEnglish
Published 20.05.2014
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2014.32.15_suppl.tps7122